Successful reintroduction of a different erythropoiesis-stimulating agent after pure red cell aplasia: Relapse after successful therapy with prednisone

Nephrology Dialysis Transplantation

Volumn 20, Issue 11, 2005, Pages 2548-2551

  Andrade, Jason ^a   Taylor, Paul A ^a   Love, Janet M ^b   Levin, Adeera ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b Kidney Function Clinic   (Canada)

Author keywords

Darbepoetin; Erythropoietin; Pure red cell aplasia; Steroids

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; IMMUNOSUPPRESSIVE AGENT; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; PREDNISONE; RECOMBINANT ERYTHROPOIETIN;

AGED; ANEMIA; ANTIBODY PRODUCTION; ANXIETY; ARTICLE; CASE REPORT; CHRONIC KIDNEY DISEASE; DEPRESSION; DRUG DOSE REGIMEN; DRUG HYPERSENSITIVITY; DRUG MEGADOSE; ERYTHROCYTE TRANSFUSION; ERYTHROPOIESIS; FATIGUE; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LOW DRUG DOSE; PRIORITY JOURNAL; PURE RED CELL ANEMIA; RECURRENT DISEASE; SIDE EFFECT; TREATMENT OUTCOME;

AGED; ANTIBODIES; ERYTHROPOIETIN; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; KIDNEY FAILURE, CHRONIC; PREDNISONE; RECURRENCE; RED-CELL APLASIA, PURE;

EID: 27644517403     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfi018     Document Type: Article

References (13)

1. Casadevall NC, Nataf J, Viron B et al. Pure red cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin. N Engl J Med 2002; 346: 469-475
2. Bennett CL, Luminari S, Nissenson AR et al. Pure red cell aplasia and epoetin therapy. N Engl J Med 2004; 351: 1404-1408
3. Casadevall N, Rossert J. Importance of biologic follow-ons: Experience with EPO. Best Pract Res Clin Haematol 2005; 18: 381-387
4. Cournoyer D, Toffelmire EB, Wells GA et al. for the Canadian PRCA Focus Group. Anti-erythropoietin antibody-mediated pure red cell aplasia after treatment with recombinant erythropoietin products: Recommendations for minimization of risk. J Am Soc Nephrol 2004; 15: 2728-2734
5. Weber G, Gross J, Kromminga A, Loew HH, Eckardt KU. Allergic skin and systemic reactions in a patient with pure red cell aplasia and anti-erythropoietin antibodies challenged with different epoetins. J Am Soc Nephrol 2002; 13: 2381-2383
6. Evens AM, Bennett CL, Luminari S. Epoetin-induced pure red-cell aplasia (PRCA): Preliminary results from the Research on Adverse Drug Events and Reports (RADAR) group. Best Pract Res Clin Haematol 2005; 18: 481-489
7. Eckardt KU, Casadevall N. Pure red-cell aplasia due to antierythropoietin antibodies. Nephrol Dial Transplant 2003; 18: 865-869.
8. Tacey R, Greway A, Smiell J et al. The detection of antierythropoietin antibodies in human serum and plasma. Part I. Validation of the protocol for a radioimmunoprecipitation assay. J Immunol Methods 2003; 283: 317-329
9. Schellekens H. Immunologic mechanisms of EPO-associated pure red cell aplasia. Best Pract Res Clin Haematol 2005; 18: 473-480
10. Casadevall N, Dupuy E, Molho-Sabatier P, Tobelem G, Varet B, Mayeux P. Autoantibodies against erythropoietin in a patient with pure red-cell aplasia. N Engl J Med 1996; 334: 630-633
11. Carson KR, Evens AM, Bennett CL, Luminari S. Clinical characteristics of erythropoietin-associated pure red cell aplasia. Best Pract Res Clin Haematol 2005; 18: 467-472
12. Mandreoli M, Finelli C, Lopez A et al. Successful resumption of epoetin alfa after rituximab treatment in a patient with pure red cell aplasia. Am J Kidney Dis 2004; 44: 757-761
13. Praditpornsilpa K, Buranasot S, Bhokaisuwan N et al. Recovery from anti-recombinant-human erythropoietin-associated pure red cell aplasia in end-stage renal disease patients after renal transplantation. Nephrol Dial Transplant 2005; 20: 626-630